All News

Found 3,475 articles

• Sorrento Therapeutics, Inc. Release: Initial Pharmacokinetic Data From TRIBECA Study Support Potential For Bioequivalence Between Cynviloq And Albumin-Bound Paclitaxel

  10/15/2014

• BioAtla Receives Broad Patent For Antibody Development

  10/14/2014

• Veristat, Inc. And Molecular Templates Inc. Enter Into Preferred Provider Agreement For Refractory Non-Hodgkin’s B-Cell Lymphoma trial

  10/13/2014

• ImmunoGen, Inc. Announces Conference Call To Discuss Its First Quarter Fiscal Year 2015 Financial Results

  10/13/2014

• CPhI Pharma Awards Winners Driving Pharma's Biggest Innovations

  10/8/2014

• Sorrento Therapeutics, Inc., Lee's Pharma Forge $49.6 Million Pact

  10/6/2014

• Catalent Pharma Solutions Expands Its Technology Offerings In Biologics, Acquires Redwood Bioscience Inc. And The SMARTag™ Technology Platform

  10/2/2014

• Oxford BioTherapeutics And Berlin-Chemie/Menarini Group Progress Antibody-Drug Conjugate As Second Clinical Development Candidate In $1 Billion Oncology Investment Alliance

  10/2/2014

• Celldex Therapeutics, Inc. Announces Publication Of Glembatumumab Vedotin Phase 1/2 Studies In The Journal Of Clinical Oncology

  9/30/2014

• ADC Therapeutics Expands Team

  9/30/2014

• Seattle Genetics, Inc., Takeda Pharmaceutical Co. Ltd.'s Cancer Drug Meets Main Goal In Phase 3 Trial

  9/29/2014

• Immunomedics, Inc. Publishes Results On Immunotherapy Of Solid Cancers Mediated By A Novel Bispecific Antibody

  9/26/2014

• Aethlon Medical And Exosome Sciences, Inc. Announce Clinical Collaboration With Boston University CTE Center To Advance Diagnostic Candidate To Detect CTE In Former NFL Players

  9/26/2014

• TauRx Therapeutics Achieves Enrollment Target For Second Phase 3 Clinical Trial Of LMTX™ In Alzheimer's Disease

  9/22/2014

• South San Francisco's Sutro Biopharma Forges $375 Million Antibody Drug Pact With Merck KGaA

  9/17/2014

• Molecular Templates Inc. Announces Completion Of $12 Million Series C Financing

  9/15/2014

• Seattle Genetics, Inc., Genmab A/S Partner In $211 Million Antibody-Drug Pact

  9/10/2014

• Pfanstiehl Gearing Up For Potent API Expansion

  9/10/2014

• Mersana Therapeutics, Inc. Strengthens Antibody-Drug Conjugate Intellectual Property Position With Issuance Of Three Additional U.S. Patents

  9/9/2014

• Sorrento Therapeutics, Inc. To Present At Two Healthcare Conferences

  9/5/2014